Wave Life Sciences (WVE) Receivables - Net (2014 - 2025)

Wave Life Sciences (WVE) has 10 years of Receivables - Net data on file, last reported at $1.3 million in Q4 2025.

• For the quarter ending Q4 2025, Receivables - Net fell 10.27% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2025 stood at $1.3 million (down 10.27% YoY), and the FY2025 full-year result was $1.3 million, down 10.27% from the prior year.
• Receivables - Net for Q4 2025 stood at $1.3 million, down from $10.0 million in the prior quarter.
• Across five years, Receivables - Net topped out at $30.0 million in Q1 2021 and bottomed at $1.3 million in Q4 2025.
• The 4-year median for Receivables - Net is $7.0 million (2023), against an average of $10.7 million.
• The widest annual swing landed in 2024, when Receivables - Net plunged 93.26%; it then advanced 25.35% in 2025.
• A 4-year view of Receivables - Net shows it stood at $22.5 million in 2021, then decreased by 6.28% to $21.1 million in 2023, then slumped by 93.26% to $1.4 million in 2024, then dropped by 10.27% to $1.3 million in 2025.
• The last three Receivables - Net figures came in at $1.3 million (Q4 2025), $10.0 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.

Peer Comparison